Riskpilot← Back to searchSign inGet full accessFANSON AS
ASActiveOrg 875368532Kirkeveien 70, 0364 OsloOther human health activities n.e.c. · NACE 8699Est. 19951 employees
Revenue 2025
NOK 1,8M
0% vs 2024
EBITDA margin
81.8%
-5% vs 2024
Equity ratio
96.4%
Financial strength
Net profit 2025
NOK 1,2M
+9% vs 2024
| Revenue | NOK 1,8M | +0% |
| EBITDA | NOK 1,5M | -5% |
| Net profit | NOK 1,2M | +9% |
| Total assets | NOK 11,6M | +12% |
| Equity | NOK 11,2M | +11% |
| Employees | 1 | — |
Legal name
FANSON AS
Org number
875368532
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
19. september 1995
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Utføre helse- og medisinske- tjenester og rådgiving oppgavene utføres i eget selskap for personer og for organisasjoner og selskaper. Selskapet driver representasjon, handel, agentur og grossist virksomhet som naturlig tilhører forretningsområdet. Videre vil selskapet investere i aksjer, firmaer og eiendom for handel, utleie, utvikling og/eller salg/utleie, samt annen virksomhet med økonomisk formål.
Address
Kirkeveien 70, 0364 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 391 | 2 054 | 1 974 | 1 836 | 1 842 |
| Staff expenses | −1 215 | −915 | −272 | −24 | −31 |
| EBITDA | 626 | 990 | 1 497 | 1 581 | 1 507 |
| Depreciation & amort. | −38 | −38 | −70 | −32 | −32 |
| EBIT | 588 | 952 | 1 428 | 1 549 | 1 475 |
| Net financials | −252 | −240 | −3 | −183 | 2 |
| Profit before tax | 335 | 712 | 1 424 | 1 366 | 1 476 |
| Tax | 74 | 157 | 314 | 306 | 325 |
| Net profit | 262 | 555 | 1 110 | 1 059 | 1 152 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 12 011 | 11 192 | 11 055 | 10 413 | 11 635 |
| Equity | 7 343 | 7 899 | 9 009 | 10 068 | 11 220 |
| Long-term debt | 4 308 | 3 008 | 1 513 | 0 | 0 |
| Short-term debt | 360 | 286 | 533 | 345 | 414 |
| Total debt | 4 668 | 3 293 | 2 046 | 345 | 414 |
EBITDA margin
81.8%
This company
15.8%
Market median
+418% vs market
20212025
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
10.3%
This company
18.4%
Market median
+44% vs market
20212025
Net profit margin
62.6%
This company
8.1%
Market median
+673% vs market
20212025
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FANSON AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sona Plavodska | Chairman | 0 companies |